Literature DB >> 30179443

Ternary-Responsive Drug Delivery with Activatable Dual Mode Contrast-Enhanced in Vivo Imaging.

Shuangshuang Ren, Jie Yang, Lan Ma, Xincong Li, Wenlei Wu, Chao Liu, Jian He1, Leiying Miao.   

Abstract

Designing a smart nanotheranostic system has recently attracted tremendous attention and is highly desirable for realizing targeted cancer therapy and early diagnosis. Herein we report the fabrication of smart nanotheranostic system using multiresponsive gatekeeping protocol of mesoporous silica nanoparticles (MSN). Acid, oxidative stress and redox sensitive manganese oxide (MnO x) coated superparamagnetic iron oxide nanoparticle (SPION) were employed as nanolids to regulate the camptothecin drug release from the channels of mesoporous silica and achieve responsive dual-mode MRI contrast. The nonvehicle showed high magnetization and T2 contrast in magnetic resonance imaging (MRI) due to the significant density of SPION onto the surface of MSN, and at the same time the MnO x shell degradation release Mn2+ which enhanced the T1MRI visualization. The efficacy of responsive drug delivery system was investigated on pancreatic cancer cells and tumor-bearing mice, and results reinforced that MnO x-SPION@MSN@CPT nonvehicle is efficacious against cancer cells. We envision that our unique and multiresponsive nanoplatform may find applications in effective delivering of imaging and therapeutic agents to wide range of diseases besides cancer.

Entities:  

Keywords:  MRI; drug delivery; manganese oxide; mesoporous silica; multiresponsive

Mesh:

Substances:

Year:  2018        PMID: 30179443     DOI: 10.1021/acsami.8b10564

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  6 in total

Review 1.  Manganese Oxide Nanoparticles As MRI Contrast Agents In Tumor Multimodal Imaging And Therapy.

Authors:  Xiaoxia Cai; Qingxia Zhu; Yun Zeng; Qi Zeng; Xueli Chen; Yonghua Zhan
Journal:  Int J Nanomedicine       Date:  2019-10-21

2.  Tantalum oxide nanoparticles as versatile contrast agents for X-ray computed tomography.

Authors:  Shatadru Chakravarty; Jeremy M L Hix; Kaitlyn A Wiewiora; Maximilian C Volk; Elizabeth Kenyon; Dorela D Shuboni-Mulligan; Barbara Blanco-Fernandez; Matti Kiupel; Jennifer Thomas; Lorenzo F Sempere; Erik M Shapiro
Journal:  Nanoscale       Date:  2020-03-25       Impact factor: 7.790

Review 3.  Magnetic Nanoparticles as MRI Contrast Agents.

Authors:  Ashish Avasthi; Carlos Caro; Esther Pozo-Torres; Manuel Pernia Leal; María Luisa García-Martín
Journal:  Top Curr Chem (Cham)       Date:  2020-05-07

4.  Combinational phototherapy and hypoxia-activated chemotherapy favoring antitumor immune responses.

Authors:  Beibei Ma; Jie Sheng; Ping Wang; Zhongying Jiang; Entomack Borrathybay
Journal:  Int J Nanomedicine       Date:  2019-06-20

Review 5.  Mesoporous Silica Nanoparticle-Based Drug Delivery Systems for the Treatment of Pancreatic Cancer: A Systematic Literature Overview.

Authors:  Etienne J Slapak; Mouad El Mandili; Maarten F Bijlsma; C Arnold Spek
Journal:  Pharmaceutics       Date:  2022-02-10       Impact factor: 6.321

6.  Self-generating oxygen enhanced mitochondrion-targeted photodynamic therapy for tumor treatment with hypoxia scavenging.

Authors:  Zhengyang Yang; Jiafeng Wang; Shichao Ai; Jianfei Sun; Xiaoli Mai; Wenxian Guan
Journal:  Theranostics       Date:  2019-09-20       Impact factor: 11.556

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.